Skip to main navigation Skip to search Skip to main content

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis

Project: Research

Project Details

StatusFinished
Effective start/end date08/29/17 → 08/28/20

Funding

  • Aurinia Pharmaceuticals Incorporated: $10,473.00